SCHOTT Pharma AG & Co. KGaA (VIE:1SXP)

Austria flag Austria · Delayed Price · Currency is EUR
14.42
+0.08 (0.56%)
At close: Jan 30, 2026
-38.69%
Market Cap2.17B -38.8%
Revenue (ttm)986.21M +3.0%
Net Income146.45M -2.2%
EPS0.97 -2.0%
Shares Outn/a
PE Ratio14.85
Forward PE15.38
Dividend0.18 (1.25%)
Ex-Dividend DateFeb 4, 2026
Volumen/a
Average Volume11
Open14.30
Previous Close14.34
Day's Range14.28 - 14.42
52-Week Range14.28 - 30.10
Betan/a
RSI38.37
Earnings DateFeb 11, 2026

About VIE:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application... [Read more]

Industry Glass Containers
Founded 1884
Employees 4,811
Stock Exchange Vienna Stock Exchange
Ticker Symbol 1SXP
Full Company Profile

Financial Performance

In fiscal year 2025, VIE:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements